Smart Health (Amst)
December 2022
With the emergence of the COVID-19 pandemic, early diagnosis of lung diseases has attracted growing attention. Generally, monitoring the breathing sound is the traditional means for assessing the status of a patient's respiratory health through auscultation; for that a stethoscope is one of the clinical tools used by physicians for diagnosis of lung disease and anomalies. On the other hand, recent technological advances have made telehealth systems a practical and effective option for health status assessment and remote patient monitoring.
View Article and Find Full Text PDFChronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide with over 3 × 10 deaths in 2019. Such an alarming figure becomes frightening when combined with the number of lost lives resulting from COVID-caused respiratory failure. Because COPD exacerbations identified early can commonly be treated at home, early symptom detections may enable a major reduction of COPD patient readmission and associated healthcare costs; this is particularly important during pandemics such as COVID-19 in which healthcare facilities are overwhelmed.
View Article and Find Full Text PDFThe COVID-19 pandemic has highlighted how the healthcare system could be overwhelmed. Telehealth stands out to be an effective solution, where patients can be monitored remotely without packing hospitals and exposing healthcare givers to the deadly virus. This article presents our Intel award winning solution for diagnosing COVID-19 related symptoms and similar contagious diseases.
View Article and Find Full Text PDF